Cabozantinib is an anti-cancer medication used to treat renal cell carcinoma and hepatocellular carcinoma. It works by inhibiting tyrosine kinases involved in tumor growth and angiogenesis. Cabozantinib is effective in managing specific cancer types. In summary, it plays a vital role in targeted cancer therapy.
Cabozantinib inhibits multiple receptor tyrosine kinases, preventing tumor cell proliferation and angiogenesis.
No published brands for this salt yet.